Cargando…
Nebivolol therapy improves QTc and QTcd parameters in heart failure patients
AIM: It has previously been shown that β-blocker therapy reduces QT dynamics in heart failure patients. The aim of this study was to demonstrate this improvement with the third-generation β-blocker, nebivolol. METHODS: A total of 72 heart failure patients with systolic dysfunction were included in t...
Autores principales: | Aksoy, SM, Cay, S, Sen, N, Cagirci, G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Clinics Cardive Publishing
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721958/ https://www.ncbi.nlm.nih.gov/pubmed/22614660 http://dx.doi.org/10.5830/CVJA-2011-046 |
Ejemplares similares
-
QTc and QTcd Measurements and Their Relationships with Left
Ventricular Hypertrophy in Hemodialysis Patients
por: Yasri, Sora, et al.
Publicado: (2018) -
Reproducibility and Reliability Of QTc and QTcd Measurements and
Their Relationships with Left Ventricular Hypertrophy in Hemodialysis
Patients
por: Alonso, Maria Angélica Gonçalves, et al.
Publicado: (2017) -
Relation Between Familial Mediterranean Fever and QT Markers (QTc, QTd, and QTcd): A Systematic Review and Meta-Analysis
por: Motawea, Karam R, et al.
Publicado: (2022) -
Chronic heart failure treatment benefits from pro-BNP-directed therapy
por: J, Aalbers
Publicado: (2011) -
Electrocardiographic abnormalities in patients with heart failure
por: Karaye, Kamilu M, et al.
Publicado: (2008)